Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00574301 · ClinicalTrials.gov registry record · Phase 1
Percutaneous Removal and Margin Ablation for Breast Cancer
A Phase 1 study, sponsored by University of Arkansas.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT00574301 is a Phase 1 study that has completed, run by University of Arkansas. The registered enrollment target is 32 participants.
The verdict
NCT00574301, a Phase 1 study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
We hypothesize that radiofrequency ablation after single-insertion image guided vacuum assisted biopsy (IVEB) can be used to achieve negative margins in small unicentric breast cancers (≤1.5 cm).
Interventions
- PROCEDURE Percutaneous Removal and Margin Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2002-03 |
| Est. Completion | 2011-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00574301
The ClinicalTrials.gov registry entry for NCT00574301 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Percutaneous Removal and Margin Ablation is the first listed.
NCT00574301 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00574301 about?
NCT00574301 is a clinical study titled "Percutaneous Removal and Margin Ablation for Breast Cancer". We hypothesize that radiofrequency ablation after single-insertion image guided vacuum assisted biopsy (IVEB) can be used to achieve negative margins in small unicentric breast cancers (≤1.5 cm).
What is the current status of trial NCT00574301?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2002-03. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00574301?
The interventions under investigation include: Percutaneous Removal and Margin Ablation (PROCEDURE).
Who is sponsoring clinical trial NCT00574301?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.